Pemetrexed Diacid Market By Cancer Type, By Therapeutic Modality, By Geographic Scope, Size and Forecast


Posted February 28, 2020 by jennysmith

The Global Pemetrexed Diacid Market was valued at USD 4,080.3 Million in 2018 and is projected to reach USD 7,168.65 Billion by 2026, growing at a CAGR of 6.7% from 2016 to 2026.

 
Pemetrexed Diacid Market Overview
According to Verified Market Research, The Global Pemetrexed Diacid Market was valued at USD 4,080.3 Million in 2018 and is projected to reach USD 7,168.65 Billion by 2026, growing at a CAGR of 6.7% from 2016 to 2026. The North American Market is expected to participate heavily in the Pemetrexed Diacid Market. This position can be attributed to the large base of existing users of Pemetrexed Diacid in the region. North America is therefore considered as the largest player in the market. Other regions such as the Asia Pacific are likely to expand in the coming years.

The latest survey on Global Pemetrexed Diacid Market is conducted covering various organizations of the industry from different geographies to come up with a 100+ page report. The study is a perfect mix of qualitative and quantitative information highlighting key market developments, challenges that industry and competition are facing along with gap analysis and new opportunity available and trend in the  Pemetrexed Diacid Market. The report bridges the historical data from 2013 to 2018 and forecasted till 2026. The report aims to present the analysis of Global Pemetrexed Diacid Market By Data consumer, By End-user, By Region – North America, Europe, South America, Asia-Pacific, Middle East, and Africa. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities.

What is Pemetrexed diacid?
Pemetrexed diacid is a drug used in the treatment of cancer. In 2004, it was approved by the Food and Drug Administration (FDA) to be used in the treatment of cancer in chemotherapy and immunotherapy. It can be used as a supplement or in combination with carboplatin or cisplatin. Eli Lilly and Company, a U.S. based company, was the pioneer of this drug and named it Alimta. However, over the years, other companies have also introduced this drug and registered it in different countries for approvals.

Get | Download Sample Report @ – https://www.verifiedmarketresearch.com/download-sample/?rid=1519&utm_source=Free&utm_medium=004

This drug has started witnessing increased application in the treatment of several forms of cancer including Lung, Liver, Colorectal, Stomach, Breast, and others. Increasing cancer occurrences, growing awareness about the benefits Pemetrexed diacid and improving spending power of the people are expected to be key drivers of this market over the next few years.

Factors influencing the market
Factors that are driving the growth of the market include the rising Instances of lung cancer. Lung cancer, also known as lung carcinoma, is a malignant lung tumor characterized by uncontrolled cell growth in tissues of the lung. This growth can spread beyond the lung by the process of metastasis into nearby tissue or other parts of the body. Most cancers that start in the lung, known as primary lung cancers, are carcinomas. The two main types are small-cell lung carcinoma (SCLC) and non-small-cell lung carcinoma (NSCLC). Pemetrexed Diacid is majorly used to treat non-small lung carcinoma.

Increasing consumption of chemotherapy drugs in developing countries. Cancer is one of the leading cause of death worldwide. it accounted for approximately 7.6 million deaths (13 percent of all causes of death). More than 70 percent of all cancer deaths occurred in low- and middle-income countries (LMICs). While it is estimated that more than 30 percent of deaths can be prevented through early detection and modifying or avoiding key risk factors, the demand for cancer treatment, especially in low-income countries, is not being adequately met.

A factor that is expected to hinder the growth of the Pemetrexed Diacid market is the high cost of chemotherapy drug development. The high cost of cancer drugs is related to numerous factors. It is very expensive to move findings from bench to bedside and to perform all the regulatory studies (including phase 1, 2, and 3 clinical trials) to gain approval.

Get More Information @ – https://www.verifiedmarketresearch.com/download-sample/?rid=1519&utm_source=Free&utm_medium=004

Global Pemetrexed Diacid Market Segment Analysis
The Global Pemetrexed Diacid market can be segmented into Consumption Type, Cancer Type, Therapeutic Modality. On the basis of Consumption Type, the Pemetrexed Diacid market is divided into in combination with cisplatin/carboplatin and as a supplement. In combination with Cisplatin/Carboplatin, the pemetrexed, along with its benefits is associated with two more drugs, one being cisplatin and another one is carboplatin. Both of these combination drugs are given by intravenous means to the patient through a drip as a part of chemotherapy. The amorphous form or powder form is also commercially available for cancer patients.

In terms of as a supplement Folic acid and Vitamin B12 supplements are provided to the patient before and during the pemetrexed-based chemotherapy session. Folic acid is an iron supplement to balance the loss of metabolic health in the patient’s body and is incorporated a week before the pemetrexid dosage is started and is in continuation throughout the treatment. Vitamin B12 is also a vitamin supplement combined with chemotherapy to keep the health statistics of the patient in line. By Cancer Type, the market is bifurcated to Lung Cancer, Liver Cancer, Colorectal Cancer, Stomach Cancer, Breast Cancer, Other Cancer Type.

The therapeutic modality segment has been segmented into Chemotherapy, Immunotherapy, and Others. Chemotherapy often called chemo is the curative procedure initialized for cancer patients. There are different ways the therapy is conducted; it can be through radiations or intravenous. The intravenous is mostly applied. There are a number of drugs used in combination with intravenous treatment during chemotherapy. Immunotherapy also called biologic therapy, is a type of cancer treatment that boosts the body’s natural defenses to fight cancer. It uses substances made by the body or in a laboratory to improve or restore immune system function. The other methods employed in cancer treatment are radiation therapy, targeted therapy, hormone therapy, and stem cell transplant.

Pemetrexed Diacid Market Competitive Landscape:
Some of the major players involved in the Global Pemetrexed Diacid Market are Eli Lilly and Company, Fresenius KABI, Teva Pharmaceutical Industries Ltd., Dr Reddy’s Laboratories, Abbott Laboratories, Cadila Healthcare Ltd, Accord Healthcare Inc., QILU Pharma Co Ltd., Accure Labs Pvt. Ltd, Pfizer Inc.. These companies will be profiled on the basis of their financials, their geographic and business segment breakdown, as well as product benchmarking. The competitive landscape section includes key development strategies and market ranking analysis of the above-mentioned players globally.

Obtain Report Details @ https://www.verifiedmarketresearch.com/product/pemetrexed-diacid-market-size-and-forecast-to-2025/?utm_source=Free&utm_medium=004
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By vmr
Country United States
Categories Business
Tags pemetrexed diacid market
Last Updated February 28, 2020